Edition:
United Kingdom

Corium International Inc (CORI.OQ)

CORI.OQ on NASDAQ Stock Exchange Global Market

12.31USD
17 Jan 2018
Change (% chg)

$0.26 (+2.16%)
Prev Close
$12.05
Open
$12.09
Day's High
$12.33
Day's Low
$11.85
Volume
62,121
Avg. Vol
67,434
52-wk High
$12.33
52-wk Low
$2.73

Latest Key Developments (Source: Significant Developments)

Corium reports Q4 loss per share $0.36
Thursday, 16 Nov 2017 

Nov 16 (Reuters) - Corium International Inc :Corium reports fourth quarter and fiscal year 2017 financial results and corporate highlights.Q4 loss per share $0.36.Q4 revenue $9.4 million versus I/B/E/S view $9.5 million.Q4 earnings per share view $-0.40 -- Thomson Reuters I/B/E/S.Corium International Inc - ‍Cash and cash equivalents as of September 30, 2017 were $57.5 million​.  Full Article

Corium International to offer common stock in public offering
Wednesday, 24 May 2017 

May 24 (Reuters) - Corium International Inc :Corium announces proposed public offering of common stock.Corium international inc - intends to use net proceeds from this offering for product development and general corporate purposes.  Full Article

Corium reports Q3 loss per share $0.34
Thursday, 4 Aug 2016 

Corium International Inc : Corium reports third quarter fiscal 2016 financial results and recent corporate highlights . Q3 revenue $10.6 million versus i/b/e/s view $8.7 million . Q3 loss per share $0.34 . Q3 earnings per share view $-0.42 -- Thomson Reuters I/B/E/S .Q3 revenue view $8.7 million -- Thomson Reuters I/B/E/S.  Full Article

Corium International says initiated reduction in workforce
Wednesday, 15 Jun 2016 

Corium International Inc : On June 14, 2016, co approved and initiated a reduction in its workforce of employees and contractors - SEC filing . Reduction affects about 17% of co's total workforce, and includes locations in San Francisco bay area, western Michigan . Expects reduction in workforce to be substantially completed by the end of June 2016, fully completed by the end of DEC 2016 .Estimates reductions will result in charges of about $0.3 million and require cash expenditures totaling about $0.5 million.  Full Article

Corium Q2 loss per share $0.47
Tuesday, 10 May 2016 

Corium International Inc : Corium reports second quarter fiscal 2016 financial results and recent corporate highlights . Q2 loss per share $0.47 . Q2 revenue $7.0 million . Q2 revenue view $9.4 million -- Thomson Reuters I/B/E/S .Q2 earnings per share view $-0.37 -- Thomson Reuters I/B/E/S.  Full Article

Corium International says positive topline results from phase 1 pk clinical study
Wednesday, 3 Feb 2016 

Corium International Inc:Announces positive topline results from phase 1 pk clinical study of once-weekly transdermal Corplex(TM) donepezil as a potential treatment of alzheimer's disease.Subjects treated with once-weekly corplex donepezil experienced no systemic adverse events unique to transdermal delivery.  Full Article

UPDATE 2-FDA rejects Agile's contraceptive patch, shares plunge

Dec 22 Agile Therapeutics Inc said on Friday the U.S. Food and Drug Administration declined to approve its contraceptive patch for the second time, sending the drug developer's shares down about 50 percent.